Accuray | ARAY - Cost Of Sales


Accuray reported $116.17M in Cost of Sales for its fiscal quarter ending in December of 2024.





Cost Of Sales Change Date
Abbott USD 5.3B 380M Mar/2026
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 37.29M 786K Sep/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 31.94M 3.22M Mar/2026
Boston Scientific USD 1.83B 8M Mar/2026
Edwards Lifesciences USD 362.6M 19.6M Mar/2026
Inogen USD 39.59M 1.27M Sep/2024
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Orthofix International USD 66.63M 6.4M Dec/2025
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Trinity Biotech USD 7.17M 666K Dec/2025